Evergreen Theragnostics

Evergreen Theragnostics, founded in 2019, is a leading US-based Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals. The company's core mission is to advance the development and manufacturing of theragnostic radiopharmaceuticals, combining therapy and diagnostics to improve patient outcomes. Their services include radiochemistry development, early-stage manufacturing, and analytical method optimization. Evergreen Theragnostics operates a state-of-the-art, nearly 14,000 square foot facility in Springfield, NJ, focusing on quality, innovation, and trust to serve patients and clients.

Notable affiliated individuals include experts with extensive experience in radiopharmaceutical commercialization and manufacturing process development. Evergreen Theragnostics has garnered significant attention for its contributions to the field of theragnostics, leveraging its advanced facility and specialized expertise to meet the growing demand for radiopharmaceuticals. Their impact is reflected in their commitment to enhancing patient care through innovative solutions and reliable manufacturing practices.